Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -8.51 |
| peg ratio | 0.11 |
| price to book ratio | -18.96 |
| price to sales ratio | 2.87 |
| enterprise value multiple | -14.12 |
| price fair value | -18.96 |
profitability ratios | |
|---|---|
| gross profit margin | 77.02% |
| operating profit margin | -24.11% |
| pretax profit margin | -35.02% |
| net profit margin | -33.69% |
| return on assets | -19.66% |
| return on equity | 397.13% |
| return on capital employed | -19.63% |
liquidity ratio | |
|---|---|
| current ratio | 1.79 |
| quick ratio | 1.29 |
| cash ratio | 0.65 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 382.49 |
| operating cycle | 462.63 |
| days of payables outstanding | 63.16 |
| cash conversion cycle | 399.47 |
| receivables turnover | 4.55 |
| payables turnover | 5.78 |
| inventory turnover | 0.95 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.84 |
| debt equity ratio | -9.57 |
| long term debt to capitalization | 1.15 |
| total debt to capitalization | 1.12 |
| interest coverage | -1.52 |
| cash flow to debt ratio | -0.12 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.22 |
| cash per share | 0.47 |
| operating cash flow per share | -0.22 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -0.12 |
| short term coverage ratios | -2.17 |
| capital expenditure coverage ratio | -41.88 |
Frequently Asked Questions
Xeris Biopharma Holdings, Inc. (XERS) published its most recent earnings results on 08-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)'s trailing twelve months ROE is 397.13%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Xeris Biopharma Holdings, Inc. (XERS) currently has a ROA of -19.66%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
XERS reported a profit margin of -33.69% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.79 in the most recent quarter. The quick ratio stood at 1.29, with a Debt/Eq ratio of -9.57.